At AAM, we measure our impact by the lives we affect. And to do that, we have a strong team working hard every day for patient access to FDA-approved, affordable, effective generics and biosimilars. In the last few months, additional professionals have joined our team. I'm proud to serve as Chief Operating Officer, and we have Administrative Assistant Kiona Casey, Policy Director Monet Stanford, Biosimilars Council Director Steven Selde and Federal Government Affairs Senior Director Joe Russo.
Outside the office, the AAM team is just as passionate. Jonathan watches British detective shows, Erik hikes with goldendoodles and Ashlee bakes up a storm. Find out more about our best-in-class colleagues and why they enjoy working at AAM. And check out our Careers page for the opportunity to join them.
By Joanne Duncan, AAM Chief Operating Officer
Published on August 27, 2021